B. Braun CeGaT Surpasses Milestone of 2000 Patient Samples Tested for Epilepsies, Will Introduce Comprehensive Genomic Testing Services for Epilepsies and Migraines at the 2014 American Epilepsy Society (AES) Annual Meeting